Stock screener

RAPP

Broke outConviction 86LongHealthcareScan · Mon, Aug 10, 2026
Ascending triangletriangle
RAPP$46.95+3.21%
ResistanceSupportVol 14Insider sell
63 bars
2
6
6
Vol MA14 353K
May 11May 28Jun 16Jul 6Jul 23Aug 10

Trade plan

LongReward : Risk0.18
Entry
Entry
46.95
Risk
Stop
39.67
-15.5% to stop
Reward
Target 1
48.26
+2.8% to target
Stretch
Target 2
49.57
+5.6% to T2
Risk : reward balance
Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

Rapport Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.rapportrx.com
Price46.95
Change+3.21%
Gap+0.52%
Rel volume3.76×
Avg volume352.49K
Avg $ vol15.08M
SMA 2042.17
SMA 5039.98
SMA 20032.66
Price vs 50+17.44%
Price vs 200+43.75%
MA stackbullish
50/200 cross
Supertrendup · 38.77
RSI (14)65
MACD hist0.45
MACD crossbull · 2d
Stoch %K / %D87 / 84
ADX (14)32
+DI / −DI27 / 9
RSI divergenceBearish
MACD divergenceBearish
ATR %+5.38%
ADR %5.78%
52w high46.95
52w low14.24
From 52w high+0.00%
Above 52w low+229.71%
New 52w highYes
SqueezeFired
Bollinger width18.26%
%B1.12
Donchian pos88.81%
Donchian high48.00
Donchian low38.62
AVWAP (52w high)46.46
vs AVWAP high+1.06%
AVWAP (52w low)30.84
vs AVWAP low+52.21%
OBV trendUp
Chaikin MF (20)0.19
Today vs 20d3.76×
Avg vol (14d)353K
Avg vol (20d)352.49K
Avg $ vol (20d)15.08M
Market cap
RS 3m (vs SPY)+8.23%
RS 6m (vs SPY)+63.93%
RS line new highNo
Trend template8/8
Technical rank92.4
1 week+15.10%
1 month+12.46%
3 months+23.42%
6 months+73.31%
1 year+204.67%
YTD+67.02%
P/E-19.54
P/B5.15
P/S
P/FCF-24.73
EPS-2.86
Div yield
ROE-26.36%
ROA-24.29%
Debt/Eq
Current15.72
EV/EBITDA-17.05
Gross margin
Net margin
Rev growth
EPS growth-42.37%
Price target54.43
Target upside19.86%
Analyst ratingBuy
Institutional113.93%
Ent. value2.12B
Revenue0
Net income-56.62M
Gross profit
Free cash flow-88.09M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out47.83M
Employees84
ListedFri, Jun 7, 2024
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeA+
Conviction86 / 100
Pattern quality50%
Tech rank92.4 / 100
Group rank86 / 100 · Leading
Status laneBroke out
Setup directionLong
Pattern familyTriangle
Resistance44.28
Support40.30
Days since event2d
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jul 23 – Jul 30
    4 scans
  2. Broke out
    Aug 10
    1 scan

Congress activity

Disclosed STOCK Act trades in RAPP

All disclosures →
No recent disclosed trades by Congress in RAPP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RAPP · 8 buys · 2 sells

InsiderSideShares
Ceesay Abraham
Chief Executive Officer · Common Stock · 2026-07-14
Sell5.48K
Ceesay Abraham
Chief Executive Officer · Common Stock · 2026-07-14
Sell2.73K
HEALY JAMES
Director · Stock Option (Right to Buy) · 2026-06-10
Grant15.2K
PEREZ ROBERT J
Director · Stock Option (Right to Buy) · 2026-06-10
Grant15.2K
Young Wendy B.
Director · Stock Option (Right to Buy) · 2026-06-10
Grant15.2K
Silva Paul M
Director · Stock Option (Right to Buy) · 2026-06-10
Grant15.2K
MARAGANORE JOHN
Director · Stock Option (Right to Buy) · 2026-06-10
Grant15.2K
PAUL STEVEN M
Director · Stock Option (Right to Buy) · 2026-06-10
Grant15.2K
Sanchez Ramiro
Director · Stock Option (Right to Buy) · 2026-06-10
Grant15.2K
Huber Reid M
Director · Stock Option (Right to Buy) · 2026-06-10
Grant15.2K

SEC filings

EDGAR filings in RAPP · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.